A breakthrough drug known as donanemab has emerged as a significant milestone in the battle against chronic forgetfulness or Alzheimer's disease, after a global trial that confirmed its ability to slow down cognitive decline.

Eli Lilly's new Alzheimer's drug shows promise of slowing down memory decline

A new Alzheimer’s drug slowed cognitive decline by 35%, according to late-stage trial results, raising the prospect of a second effective treatment for the disease. WION tells you more in this report.

Beginning of an end to Alzheimer's?

There's been a breakthrough in Alzheimer's treatment. A new drug is said to be able to slow down cognitive decline in Alzheimer's patients. Priyanka Sharma brings you the details.

Gravitas: Breakthrough in Alzheimer's treatment